New Zealand Black (NZB) autoimmune mice exhibit progressive, age-dependent reduction in bone marrow pre-B cells. To ascertain the capacity of NZB bone marrow 8220-cells t o generate pre-B cells in a supportive environment, B-lineage (8220') cell-depleted and T-cell-depleted bone marrow cells from NZB mice at 1 t o 3,6, and 10 t o 11 months of age were adoptively transferred into irradiated (200R) C.Bl7 severe combined immunodeficient (SCID) mice. Bone marrow pre-B cells (slg" CD43[S7]-B220 ') were assessed 3 and 10 weeks posttransfer. Pre-B cells and B cells were reconstituted in SClD recipients of older NZB progenitor cells by 10 weeks posttransplant, in contrast to the very low numbers of pre-B cells present in the donor bone marrow. However, B220-bone marrow progenitor cells from greater than 10-month-old NZB donors were deficient in the reconstitution of both pre-B and B cells in SClD recipients at 3 weeks post-LYMPHOPOIESIS IS modulated by a complex network of both positive and negative cytokines, as well as cellto-cell interactions.'.' In most murine strains, B lymphopoiesis within the bone marrow decreases during sene~cence.~,~ In contrast, the autoimmune New Zealand Black (NZB) strain shows accelerated B-cell progenitor loss in the bone marrow. In previous studies by ourselves5 and others: decreased numbers of pre-B cells were observed with age in NZB bone marrow. However, the extent to which the function of earlier progenitors is also affected with age has not been ascertained. Furthermore, the molecular and cellular mechanisms responsible for the abnormal B-lineage cell development in the NZB strain remain unclear. Both in vitro and in vivo experiments suggest that microenvironmental elements required for promoting pre-B -cell development and differentiation remain functional in this train.^.^ The age-associated decline in Blineage cell development in NZB mice may be associated with their temporally progressive autoimmune disease.
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To evaluate the function of early B-lineage precursors in NZB mice with age, B-lineage (B2207 cell-depleted bone marrow from NZB mice of different ages was adoptively transferred into immunodeficient C.B 17 severe combined immunodeficient (SCID) recipients and reconstitution of both B cells and their pre-B-cell precursors were assessed. Our results suggest that (1) B220-bone marrow cells from older NZB mice were capable of reconstituting the pre-B
transfer. This reflected a slower kinetics of repopulation, because older NZB --$ SClD recipients had numbers of both pre-B and B cells similar t o recipients of young NZB progenitor cells by 10 weeks posttransplant. Adoptive transfer of equal mixtures of BALBIc and older NZB bone marrow B220-progenitor cells into irradiated CB17 SClD recipients failed t o demonstrate active suppression. These results suggest that, with age, NZB bone marrow has reduced numbers andlor function of early 8220-B-lineage progenitors. Consistent with this hypothesis, 8220-bone marrow cells from older NZB mice were deficient in progenitors capable of yielding interleukin-7 (IL-7) responsive pre-B cells in vitro on stimulation with the pre-B-cell potentiating factor, insulin-like growth factor 1 (IGF-l). 0 1995 b y The American Society of Hematology.
and B-cell compartments in SCID recipients and (2) the slower kinetics of repopulation from older NZB progenitor cells suggests reduced numbers and/or function of early B220-B-lineage progenitors. These results suggest that bone marrow from NZB mice retains the inherent capacity to generate pre-B and B cells with age, but that this function is inhibited in older NZB adults.
MATERIALS AND METHODS
Mice. NZB/BINJ mice 1 to 6 months of age were purchased from Jackson Laboratories, Bar Harbor, ME and housed at the University of Miami School of Medicine. BALBk mice (1 to 2 months of age) were bred at the University of Miami. CB17 SCID mice, used at 5 weeks of age, were a generous gift from Dr Joan SteinStreilein, Department of Medicine, University of Miami School of Medicine, Miami, FL. All three strains used share identity in the major histocompatibility complex (MHC) (H-2d). Both males and females were used as recipients and donors, and equivalent results were obtained in all combinations. 8220-cell preparation and transfer. Village, CA) was added per 2 X IO5 bone marrow cells and plated in triplicate. Colonies with greater than 25 cells were counted on day 7 using an inverted microscope. IL-7 colony-forming unit (CFU) assays were modified in some experiments to permit in vitro analysis of IL-7-responsive pre-B cells generated from B220-progenitors on stimulation with rIGF-l.9.'o B220-bone marrow cells (2.5 x 10') were cultured as in typical IL-7 CFU assays, but with added human rIGF-1 (60 ng/mL) (Biosource International). Colonies were counted on day 7, as above.
RESULTS

NZB mice exhibit decreased numbers of bone marrow pre-B cells with
age. Consistent with previous result^,^.^ the NZB donors used in our adoptive transfer experiments exhibited reduced numbers of bone marrow small pre-B cells (sIgM-S7-B220+)".'* ( Fig 1A) . Numbers of pre-B cells at 6 months of age were, on average, less than 20% of the numbers observed in 1-to 2-month-old NZB mice; at ages of 10 to 11 months, few pre-B cells were detected by fluorescence flow cytometry in NZB mice. Pro-B and pro-pre-B cells, characterized as sIgM-S7+ B220+,",'* are also decreased with age in NZB bone marrow (Fig 1B) . However, in contrast with their diminished pre-B cells, NZB mice at 6 months of age or more retain significant numbers of pro-B and pro-pre-B cells, equivalent to approximately 50% of that seen in young NZB bone marrow (Fig IB) . Nonautoimmune BALB/c mice exhibited little change in numbers of IgM-S7' B220+ pro-B cells or IgM-S7-B220+ pre-B cells through 12 months of age (data not shown), consistent with previous report^.',^ Reconstitution of B-lineage precursors in SCID recipients of NZB B220-bone marrow cells is dependent on donor age.
Young (5-week-old) 200R irradiated C.Bl7 SCID mice were adoptively transferred with 1 X lo6 bone marrow cells from NZB mice 1 to 11 months of age; similar results were also obtained with 5 X IO6 cells transferred (data not shown). Importantly, the bone marrow cells in all experiments were extensively depleted of B-lineage B220' cells by panning and of Thy 1. a~tivity,'~ pre-B and B cells detected in the transferred recipients are of donor origin. As shown in Fig 2, SCID recipients of young NZB (1 to 2 months) B220-bone marrow cells were reconstituted with appreciable numbers of bone marrow sIgM-S7-B220' small pre-B cells within a 3-week period. Furthermore, earlier B220+ pro-B and pro-pre-B cells bearing the S7 surface antigen"." were increased in these recipients over numbers detected in untransferred, 200R irradiated SCID mice (Fig  2) . SCID recipients of B220-bone marrow cells from 6-month-old NZB donors were heterogenous in their capacity to reconstitute pre-B cells. Although some recipients produced only low numbers of pre-B cells 3 weeks posttransplant, similar to that seen in the original donor marrow, most recipients yielded numbers of small pre-B cells comparable to those seen in recipients of young NZB bone marrow progenitor cells (Fig 2A) . In contrast to the above results, reconstitution of SCID mice with B220-bone marrow cells from NZB mice at 10 to 11 months of age uniformly resulted in significantly reduced reconstitution of small pre-B cells within the bone marrow (Fig 2A) . Indeed, the majority of recipients of 10-to 1 l-month-old NZB bone marrow B220-cells produced small pre-B cell numbers which were less than 5% of that seen when young NZB donors were used. When SCID recipients of 10-to 11-month-old NZB bone marrow B220-cells were examined at 10 weeks posttransfer, the numbers of bone marrow pre-B cells were increased over those observed at 3 weeks posttransfer and were now similar to those seen with recipients of young NZB progenitor cells at 10 weeks posttransfer as shown by representative examples in Table 1 . Notably, numbers of both pre-B cells and splenic B cells detected in SCID recipients of aged NZB bone marrow cells at 10 weeks were equal to or greater than those seen in recipients of young NZB bone marrow cells.
The extent of reconstitution of sIgM-S7+ B220' B-cell precursors also varied with age of the NZB donors. As shown Pre-B cells were defined as slgM-S7-B220' bone marrow cells. in Fig 2B, the numbers of pro-B/pro-pre-B cells in the bone marrow of the SCID recipients declined with age of the NZB donor, although with 10-1 1 month old NZB donors, appreciable numbers of these early B-lineage precursors were readily detected. Both the proportions and absolute numbers of B-lineage cells within the bone marrow of SCID recipients of NZB B220-progenitor cells were affected by the age of the donor. Importantly, average total numbers of bone marrow cells present in the SCID recipients did not differ significantly with age of the NZB donors used (1 to 2 months NZB + SCID, 26 2 7 X lo6 cells; 10 to 11 months NZB + SCID, 19 2 9 X lo6 cells per femurltibia pair).
Incidences of IL-7-responsive B-lineage precursors in the bone marrow of SCID recipients is dependent on NZB donor age. Previous results have shown that subpopulations of S7+ B220+ B lineage precursors proliferate in vitro in response to IL-7; S7-B220' small pre-B cells lack this capacity.".'4 Bone marrow cells from SCID mice fail to generate IL-7-dependent B-lineage cell colonies in semisolid media.I4 Because SCID mice do not produce IL-7-responsive B-lineage precursors, their Occurrence in SCID recipients of NZB bone marrow progenitors is consistent with their donor origin. SCID recipients of NZB bone marrow showed a reduction in IL-7 CFU associated with age of the NZB donor used at 3 weeks posttransfer (Fig 3) ; however, by 10 weeks posttransfer, IL-7 CFUs in the SCID recipients were equivalent among NZB donor age groups (data not shown). These results suggest that the decrease in preB-cell development in NZB mice and the reduced production of pre-B cells early after transplant in NZB + SCID recipients also extends to IL-7-dependent pre-B cells.
NZB mice show an age-dependent loss of B220-progenitors responsive to IL-7 plus insulin-like growth factor I (IGF-l). B220-bone marrow cells fail to generate significant pre-B-cell colonies in IL-7 CFU assays'' (Fig 4) . However, rIGF-l has been shown to potentiate induction of IL-7-responsive pre-B cells from early B220-pro-B-cell progenitors?" To ascertain the capacity of NZB bone marrow B220-cells to develop into IL-7-responsive pre-B cells in vitro, modified IL-7 CFU assays were conducted wherein B220-bone marrow cells were costimulated with both rIGF-1 and IL-7. Inclusion of rIGF-1 resulted in significant numbers of lymphoid colonies in IL-7 CFU assays from 1 to 2-month old BALB/c B220-bone marrow cells (Fig 4) with no decrease through 12 months of age (data not shown). The pre-B-cell nature of the colonies was established by their staining for B220 and 6C3/BP-1 (data not shown). With age, the capacity of B220-bone marrow cells from NZB mice to yield IL-7 CFU under these conditions decreased (Fig 4) . These results suggest that NZB mice become deficient in bone marrow B220-cells capable of yielding IL-7-responsive pre-B cells in vitro with age.
Splenic B-cell development is reduced in SCID recipients of older NZB bone marrow progenitor cells. Not surprisingly, SCID mice adoptively transferred with bone marrow B220-cells from older NZB donors had significantly reduced numbers of splenic B cells (IgM' B220+), coincidental with reduced numbers of bone marrow pre-B cells 3 weeks posttransplant (Fig 5) . Few, if any, of these splenic B cells expressed either the Lyl or Mac1 antigens (data not shown). As was seen for pre-B cells in the bone marrow, splenic B-cell numbers also increased significantly in recipients of older NZB progenitor cells between 3 and 10 weeks posttransplant ( Table 1) . Unlike normal mice, the majority of splenic B cells in adult NZB mice fail to express significant surface staining for the CD23 antigen." SCID recipients of BALB/c bone marrow B220-cells generated splenic B cells most; (greater than 90%) were CD23+. In contrast, CD23-B cells predominated (greater than 90%) in the spleens of SCID mice reconstituted with NZB bone marrow progenitor cells regardless of the age of the donor (data not shown). Therefore, the splenic B cells generated in SCID mice reconstituted with NZB bone marrow progenitors were not equivalent to normal splenic B cells and resembled the splenic B cells seen in the NZB donors in surface phenotype. Consistent with the production of pre-B cells in the bone marrow, SCID recipients of BALB/c and NZB bone marrow progenitor mixtures also possessed substantial numbers of splenic B cells (Fig 7B) . BALB/c B cells were identified as positive for the IgM" allotype by specific MoAb staining; B cells lacking IgM" staining (IgM"-) were presumed to be of NZB origin. Total numbers of splenic B cells in SCID recipients of BALB/c + older NZB bone marrow progenitors were similar to those seen in recipients of BALB/c bone marrow cells alone or together with young NZB bone marrow progenitors (Fig 7) . Both IgM"+ and 1gM"-B cells were detected in the spleens of all recipients examined regardless of age of the NZB donor. IgM"' B cells in recipients of BALB/c plus either young or old NZB bone marrow progenitor cell mixtures comprised approximately 50% to 80% of total splenic B cells. Notably, the numbers of BALB/c B cells produced in the presence of transferred young NZB or older NZB bone marrow progenitors did not differ significantly (Fig 7B) . Riley, manuscript submitted, 1994) . Bone marrow stem cells capable of yielding CFU-S have been reported not to change with age in NZB mice"; however, the B-lineage generative capacity of NZB early (B220-) progenitors has not been directly ascertained.
Our results indicate that NZB bone marrow B220-cells are progressively less capable of generating pre-B cells and peripheral B cells with increasing age of the NZB donors in short-term adoptive transfers. Therefore, even in the presence of a supportive (SCID) microenvironment for B lymphopoiesis, the pre-B-cell deficient phenotype of older NZB bone marrow is retained at early time points (3 weeks) posttransplant. Importantly, donor age-dependent differences in pre-B and B-cell reconstitution seen early posttransplant were not apparent at 10 weeks posttransplant. These data suggest that, with age, NZB bone marrow exhibits a functional depletion of B220-B-lineage precursor cells. As a result, the time necessary for pre-B and B-cell restoration in NZB -SCID recipients is increased with age of the NZB donor. Previous results by Dorshkind et alZ2 have shown that bone marrow cells from older NZB mice reconstitute B cells in SCID recipients within 10 to 12 weeks, suggesting that a microenvironmental defect in NZB bone marrow contributes to abnormalities of B-cell development. Analysis of our adoptive transfer experiments at 10 weeks posttransplant are consistent with the above results. However, analysis of our experiments at 3 weeks posttransplant showed a decline in B-lineage cell developmental capacity among older NZB B220-progenitor cells. Notably, the age-associated decreased capacity of NZB B220-bone marrow cells, on stimulation with rIGF-I, to yield pre-B cells responsive to IL-7 in vitro are also consistent with a numerical and/or functional reduction in B220-B-lineage precursors with age in NZB mice. Our results are also supported by the in vitro results of Ohmori et alZ3 wherein the frequency of B220-bone marrow B-lineage progenitors capable of growth on PA6 stromal cells was decreased even in young NZB mice. Taken together, these data support the hypothesis that abnormal, age-associated microenvironmental regulation underlies the decline in pre-B-cell numbers seen in bone marrow from older NZB mice and that abnormal B-lineage cell development extends to early B220-progenitor cells in this autoimmune strain.
To directly test for negative regulation of B lymphopoiesis in NZB mice, adoptive transfer of mixtures of BALB/c and NZB bone marrow B220-cells was performed. Notably, mixtures of BALBk and young NZB bone marrow progenitors yielded pre-B cells in bone marrow as well as B cells in spleen of both BALBlc (IgM"+) and NZB (IgW-) origin with no evidence of positive or negative allogeneic effects. B cells are rare in peripheral lymphoid tissues of SCID mice at 5 3 months of age"; thus, the IgW-B cells present in our adoptive transfers into 5-week old SCID mice are of NZB origin. Note that transfer of BALB/c bone marrow progenitors alone generates no 1gM"-B cells in young (5 weeks old) irradiated SCID recipients and transfer of older NZB progenitors likewise generates few 1gM"-B cells. Our observation of comparable numbers of pre-B cells in bone marrow and, in particular, peripheral BALB/c B cells generated in recipients of BALB/c progenitor cells together with older NZB progenitor cells, provides no evidence that supports the possible active suppression of B lymphopoiesis by transferred NZB bone marrow cell elements.
The basis for the environmental dysfunction responsible for the alteration of B lymphopoiesis in NZB mice is not The environmental dysfunction in NZB mice probably does not reside in the supportive stroma per se, but rather in imposed downregulation of stromal cells andor B-lineage cell precursor function. Such negative regulation might include cytokines such as y-interferon, a potent inhibitor of pre-B-cell responses to IL-7,27s28 which is increased in the spleens of older NZB mice:9 andor autoantibodies. Of interest, NZB mice, with age, become increasingly hypergammaglobulinemic and have increased B1 B cell Administration of high doses of normal Ig or activated peritoneal B1 B cells into BALBk mice selectively decreases proportions of bone marrow pre-B Therefore, the progressive autoimmune abnormalities in NZB mice may contribute to the abnormal downregulation of B lymphopoiesis in this strain.
